Relmada Therapeutics, Inc.
(RLMD - NASDAQ)
7,03 USD
📋 Profilo Aziendale

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders.

|